-
1دورية أكاديمية
المؤلفون: Durier, Christine, Ninove, Laetitia, van der Werf, Sylvie, Lefebvre, Maeva, Desaint, Corinne, Bauer, Rebecca, Attia, Mikael, Lecompte, Anne-Sophie, Lachatre, Marie, Maakaroun-Vermesse, Zoha, Nicolas, Jean-François, Verdon, Renaud, Kiladjian, Jean-Jacques, Loubet, Paul, Schmidt-Mutter, Catherine, Corbin, Violaine, Ansart, Séverine, Melica, Giovanna, Resch, Martine, Netzer, Emmanuelle, Kherabi, Yousra, Tardieu, Raphaëlle, Lelièvre, Jean-Daniel, Tartour, Eric, Meyer, Laurence, de Lamballerie, Xavier, Launay, Odile
المساهمون: CIC Cochin Pasteur (CIC 1417), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôtel-Dieu-Groupe hospitalier Broca-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), CIC Saint Louis (CIC-1427), Institut National de la Santé et de la Recherche Médicale (INSERM)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Cité (UPCité), Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Hôpital Européen Georges Pompidou APHP (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
المصدر: ISSN: 2666-9919 ; Infectious Diseases Now ; https://u-paris.hal.science/hal-04596145Test ; Infectious Diseases Now, 2024, 54 (5), pp.104886. ⟨10.1016/j.idnow.2024.104886⟩ ; https://www.sciencedirect.com/science/article/pii/S2666991924000411Test.
مصطلحات موضوعية: Breakthrough infections, COVID-19 mRNA vaccine, Neutralization antibodies, Omicron, COVID-19 mRNA vaccine Breakthrough infections Omicron Neutralization antibodies, [SDV]Life Sciences [q-bio]
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38494117; hal-04596145; https://u-paris.hal.science/hal-04596145Test; https://u-paris.hal.science/hal-04596145/documentTest; https://u-paris.hal.science/hal-04596145/file/1-s2.0-S2666991924000411-main.pdfTest; PUBMED: 38494117
الإتاحة: https://doi.org/10.1016/j.idnow.2024.104886Test
https://u-paris.hal.science/hal-04596145Test
https://u-paris.hal.science/hal-04596145/documentTest
https://u-paris.hal.science/hal-04596145/file/1-s2.0-S2666991924000411-main.pdfTest -
2دورية أكاديمية
المؤلفون: Janku, Filip, Kim, Tae Min, Iyer, Gopakumar, Spreafico, Anna, Elez, Elena, de Jonge, Maja, Yamamoto, Noboru, van der Wekken, Anthonie J., Ascierto, Paolo Antonio, Maur, Michela, Marmé, Frederik, Kiladjian, Jean Jacques, Basu, Sumit, Baffert, Fabienne, Buigues, Amparo, Chen, Chi, Cooke, Vesselina, Giorgetti, Elisa, Kim, Jaeyeon, McCarthy, Fiona, Moschetta, Michele, Dummer, Reinhard
المصدر: Janku , F , Kim , T M , Iyer , G , Spreafico , A , Elez , E , de Jonge , M , Yamamoto , N , van der Wekken , A J , Ascierto , P A , Maur , M , Marmé , F , Kiladjian , J J , Basu , S , Baffert , F , Buigues , A , Chen , C , Cooke , V , Giorgetti , E , Kim , J , McCarthy , F , Moschetta , M & Dummer , R 2024 , ' First-in-human study ....
مصطلحات موضوعية: /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being
الإتاحة: https://doi.org/10.1016/j.ejca.2023.113458Test
https://pure.eur.nl/en/publications/0962e14d-593c-4d05-9d27-1f763155c20aTest
http://www.scopus.com/inward/record.url?scp=85178106503&partnerID=8YFLogxKTest -
3دورية أكاديمية
المؤلفون: Oh, Stephen, Verstovsek, MD, PhD, Professor of Medicine, Srdan, Gupta, Vikas, Platzbecker, Uwe, Devos, Timothy, Kiladjian, Jean-Jacques, Fox, Maria Laura
المساهمون: Institut Català de la Salut, Oh ST Division of Hematology, Washington University School of Medicine, St. Louis, Missouri, USA. Verstovsek S Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Gupta V Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. Platzbecker U Clinic of Hematology, Cellular Therapy, and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany. Devos T Microbiology, and Immunology, Laboratory of Molecular Immunology (Rega Institute), Department of Hematology, University Hospitals Leuven and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium. Kiladjian JJ Université Paris Cité, AP-HP, Hopital Saint-Louis, Centre d’Investigations Cliniques, Paris, France. Fox ML Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Mielofibrosi - Tractament, Proteïnes quinases - Inhibidors - Ús terapèutic, DISEASES::Hemic and Lymphatic Diseases::Hematologic Diseases::Bone Marrow Diseases::Myeloproliferative Disorders::Primary Myelofibrosis, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors::Janus Kinase Inhibitors, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades hematológicas::enfermedades de la médula ósea::trastornos mieloproliferativos::mielofibrosis primaria, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas::inhibidores de las cinasas Janus
وصف الملف: application/pdf
العلاقة: eJHaem;5(1); https://doi.org/10.1002/jha2.854Test; Oh ST, Verstovsek S, Gupta V, Platzbecker U, Devos T, Kiladjian JJ, et al. Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. eJHaem. 2024 Feb 5;5(1):105–16.; https://hdl.handle.net/11351/11154Test
-
4دورية أكاديمية
المؤلفون: GALTIER, Jean, DREVON, Louis, LE BRIS, Yannick, GIRAUDIER, Stephane, WEMEAU, Mathieu, LEGROS, Laurence, LUQUE PAZ, Damien, GIRODON, François, KILADJIAN, Jean-Jacques, MESGUICH, Charles, PARRENS, Marie, MEDIAVILLA, Clémence, ROY, Lydia, GUY, Alexandre, MANSIER, Olivier, IANOTTO, Jean-Christophe, JAMES, Chloe
مصطلحات موضوعية: Sciences du Vivant [q-bio]/Médecine humaine et pathologie
الإتاحة: https://doi.org/20.500.12278/188966Test
https://doi.org/10.3324/haematol.2023.284488Test
https://oskar-bordeaux.fr/handle/20.500.12278/188966Test
https://hdl.handle.net/20.500.12278/188966Test -
5دورية أكاديمية
المصدر: Cancer ; volume 130, issue 12, page 2091-2097 ; ISSN 0008-543X 1097-0142
-
6دورية أكاديمية
المؤلفون: Gou, Panhong, Liu, Duanya, Ganesan, Saravanan, Lauret, Evelyne, Maslah, Nabih, Parietti, Veronique, Zhang, Wenchao, Meignin, Véronique, Kiladjian, Jean-Jacques, Cassinat, Bruno, Giraudier, Stephane
المصدر: Blood Cancer Journal ; volume 14, issue 1 ; ISSN 2044-5385
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1038/s41408-023-00969-6Test
https://www.nature.com/articles/s41408-023-00969-6.pdfTest
https://www.nature.com/articles/s41408-023-00969-6Test -
7دورية أكاديمية
المؤلفون: de Latour, Régis Peffault, Szer, Jeff, Weitz, Ilene, Röth, Alexander, Höchsmann, Britta, Panse, Jens, Usuki, Kensuke, Griffin, Morag, Kiladjian, Jean-Jacques, Castro, Carlos de, Nishimori, Hisakazu, Al-Adhami, Mohammed, Deschatelets, Pascal, Francois, Cedric, Risitano, Antonio, Hillmen, Peter
المصدر: Future Rare Diseases ; volume 4, issue 1 ; ISSN 2399-5270
-
8دورية أكاديمية
المؤلفون: Ghrieb, Zineb, Walter-Petrich, Anouk, Huang, Jin, Chevret, Sylvie, Montlahuc, Claire, Resche-Rigon, Matthieu, Kiladjian, Jean-Jacques, Allaoua, Souhil, Abdeljalil, Nabil
المصدر: Therapies ; ISSN 0040-5957
مصطلحات موضوعية: Pharmacology (medical)
الإتاحة: https://doi.org/10.1016/j.therap.2023.12.004Test
https://api.elsevier.com/content/article/PII:S0040595724000039?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0040595724000039?httpAccept=text/plainTest -
9دورية أكاديمية
المؤلفون: Mughal, Tariq I, Pemmaraju, Naveen, Psaila, Bethan, Radich, Jerald, Bose, Prithviraj, Lion, Thomas, Kiladjian, Jean‐Jacques, Rampal, Raajit, Jain, Tania, Verstovsek, Srdnan, Yacoub, Abdulraheem, Cortes, Jorge E, Mesa, Ruben, Saglio, Giuseppe, Etten, Richard A
المصدر: Hematological Oncology. 38(5)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Hematology, Rare Diseases, Orphan Drug, Cancer, Anemia, Biomarkers, Biomarkers, Tumor, Combined Modality Therapy, Disease Management, Disease Susceptibility, Drug Development, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Molecular Diagnostic Techniques, Molecular Targeted Therapy, Myeloproliferative Disorders, Prognosis, Single-Cell Analysis, Translational Research, Biomedical, Treatment Outcome, BCR-ABL1 mutants, genomic risk scores, interferon-alpha, luspatercept, non-JAK-STAT therapies, single-cell genomics, Cardiorespiratory Medicine and Haematology, Immunology, Cardiovascular medicine and haematology
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/2pc6r67jTest
-
10دورية أكاديمية
المؤلفون: Griffin, Morag, Szer, Jeff, Weitz, Ilene, Röth, Alexander, Höchsmann, Britta, Panse, Jens, Usuki, Kensuke, Hillmen, Peter, Kiladjian, Jean-Jacques, Castro, Carlos de, Nishimori, Hisakazu, Tan, Lisa, Deschatelets, Pascal, Francois, Cedric, Grossi, Federico, Ajayi, Temitayo, Risitano, Antonio, de la Tour, Régis Peffault
المساهمون: AbbVie, Alexion, Apellis, Astellas, Astellas-Amgen-Biopharma, Bristol-Myers Squibb, Celgene, Chugai, Daiichi Sankyo, Gilead Sciences, Janssen Biotech, Kyowa Kirin, Mundipharma, Nippon Boehringer Ingelheim
المصدر: Future Rare Diseases ; volume 3, issue 3 ; ISSN 2399-5270